Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

376.35 USD +5.31 (+1.43%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Illumina Inc

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale
Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a... 
From Business Wire News Releases
Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling
With genetic sequencing at the forefront of precision medicine, Illumina (NASDAQ: ILMN) is pleased to announce a portfolio of new and expanded oncology partnerships that further the company’s... 
From Business Wire News Releases
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
From GlobeNewswire News Releases
Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure
Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2... 
From Business Wire News Releases
Illumina to Webcast Upcoming Investor Conference Presentations
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. 
From Business Wire News Releases
Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing
Illumina and Harvard Pilgrim Health Care expand access to whole-genome sequencing for genetic disease testing. 
From Business Wire News Releases
Companion Diagnostics Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2020-2025 | ExpertMarketResearch.com
Tags Financial Content Research Newswire Reportedtimes
From iCrowdNewswire
Illumina to Webcast Upcoming Investor Conference Presentation
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. 
From Business Wire News Releases
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes. 
From PR Newswire
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
. Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1... 
From Business Wire News Releases
Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA
Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of DNA data... 
From Business Wire News Releases
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020. 
From Business Wire News Releases
IDbyDNA and Illumina Launch New Rapid Test to Better Detect Respiratory Co-Infections and Identify Antibiotic Resistant Pathogens
New Panel to Provide Support During Onset of Flu Season in the Midst of the COVID-19 Pandemic 
From PR Newswire
Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020. 
From Business Wire News Releases
Illumina to Webcast Upcoming Investor Conference Presentation
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. 
From Business Wire News Releases
Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
Illumina, Inc. (NASDAQ: ILMN) and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which... 
From Business Wire News Releases
Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
Illumina Welcomes Kathryne Reeves as Chief Marketing Officer 
From Business Wire News Releases
Wouter Meuleman Promoted to Partner of Illumina Ventures
Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, Inc. (NASDAQ: ILMN), today announced the promotion of Wouter Meuleman to Partner. 
From PR Newswire
Illumina to Webcast Upcoming Investor Conference Presentation
UBS Genomics 2.0 and Medtech Innovations Summit 
From Business Wire News Releases
Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome
Illumina, Inc. (Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 Reagent Kit. The new NovaSeq 6000 v1.5 Reagent Kits aim to make whole genome sequencing... 
From Business Wire News Releases
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020. 
From Business Wire News Releases
Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Q2 2020 Earnings Release Date Announcement 
From Business Wire News Releases
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight... 
From Business Wire News Releases
Illumina Accelerator Welcomes First Global Cohort of Genomics Startups
Illumina, Inc. (NASDAQ:ILMN) has selected seven early-stage companies to join the first global cohort of Illumina Accelerator, the company creation engine focused on partnering with entrepreneurs to... 
From Business Wire News Releases
Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that... 
From Business Wire News Releases
Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies
Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI... 
From Business Wire News Releases
Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use... 
From Business Wire News Releases
Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment
Strategic investment from Illumina and others enables large-scale COVID-19 testing using next generation sequencing 
From PR Newswire
Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our... 
From Business Wire News Releases
Natera and Illumina Settle Patent Dispute
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and Illumina Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing platforms, today announced that they... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.